243 related articles for article (PubMed ID: 35222426)
1. Endothelin-A Receptor Antagonist Alleviates Allergic Airway Inflammation
Zhang X; Chen Z; Zuo S; Sun H; Li X; Lu X; Xing Z; Chen M; Liu J; Xiao G; He Y
Front Immunol; 2022; 13():835953. PubMed ID: 35222426
[TBL] [Abstract][Full Text] [Related]
2. Bilirubin represents a negative regulator of ILC2 in allergic airway inflammation.
He J; Jiang G; Li X; Xiao Q; Chen Y; Xu H; Liu G; Lei A; Zhou P; Shi K; Yang Q; Zhao M; Yao Z; Zhou J
Mucosal Immunol; 2022 Feb; 15(2):314-326. PubMed ID: 34686839
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation.
Johansson K; Malmhäll C; Ramos-Ramírez P; Rådinger M
J Allergy Clin Immunol; 2017 Mar; 139(3):1007-1016.e9. PubMed ID: 27492144
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptor 2 engagement promotes group 2 innate lymphoid cell expansion and enhances airway hyperreactivity.
Hurrell BP; Helou DG; Shafiei-Jahani P; Howard E; Painter JD; Quach C; Akbari O
J Allergy Clin Immunol; 2022 May; 149(5):1628-1642.e10. PubMed ID: 34673048
[TBL] [Abstract][Full Text] [Related]
5. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
[TBL] [Abstract][Full Text] [Related]
6. Eosinophils promote effector functions of lung group 2 innate lymphoid cells in allergic airway inflammation in mice.
LeSuer WE; Kienzl M; Ochkur SI; Schicho R; Doyle AD; Wright BL; Rank MA; Krupnick AS; Kita H; Jacobsen EA
J Allergy Clin Immunol; 2023 Aug; 152(2):469-485.e10. PubMed ID: 37028525
[TBL] [Abstract][Full Text] [Related]
7. Regulation of type 2 innate lymphoid cell-dependent airway hyperreactivity by butyrate.
Thio CL; Chi PY; Lai AC; Chang YJ
J Allergy Clin Immunol; 2018 Dec; 142(6):1867-1883.e12. PubMed ID: 29522844
[TBL] [Abstract][Full Text] [Related]
8. The NF-κB Transcription Factor c-Rel Modulates Group 2 Innate Lymphoid Cell Effector Functions and Drives Allergic Airway Inflammation.
Mindt BC; Krisna SS; Duerr CU; Mancini M; Richer L; Vidal SM; Gerondakis S; Langlais D; Fritz JH
Front Immunol; 2021; 12():664218. PubMed ID: 34867937
[TBL] [Abstract][Full Text] [Related]
9. IRF-7 Is a Critical Regulator of Type 2 Innate Lymphoid Cells in Allergic Airway Inflammation.
He J; Yang Q; Xiao Q; Lei A; Li X; Zhou P; Liu T; Zhang L; Shi K; Yang Q; Dong J; Zhou J
Cell Rep; 2019 Nov; 29(9):2718-2730.e6. PubMed ID: 31775040
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of type 2 innate lymphoid cells and T
De Grove KC; Provoost S; Hendriks RW; McKenzie ANJ; Seys LJM; Kumar S; Maes T; Brusselle GG; Joos GF
J Allergy Clin Immunol; 2017 Jan; 139(1):246-257.e4. PubMed ID: 27315767
[TBL] [Abstract][Full Text] [Related]
11. Adenosine restrains ILC2-driven allergic airway inflammation via A2A receptor.
Xiao Q; Han X; Liu G; Zhou D; Zhang L; He J; Xu H; Zhou P; Yang Q; Chen J; Zhou J; Jiang G; Yao Z
Mucosal Immunol; 2022 Feb; 15(2):338-350. PubMed ID: 34921233
[TBL] [Abstract][Full Text] [Related]
12. A Selective α7 Nicotinic Acetylcholine Receptor Agonist, PNU-282987, Attenuates ILC2s Activation and
Yuan F; Jiang L; Li Q; Sokulsky L; Wanyan Y; Wang L; Liu X; Zhou L; Tay HL; Zhang G; Yang M; Li F
Front Immunol; 2020; 11():598165. PubMed ID: 33597946
[TBL] [Abstract][Full Text] [Related]
13. ICAM-1 controls development and function of ILC2.
Lei AH; Xiao Q; Liu GY; Shi K; Yang Q; Li X; Liu YF; Wang HK; Cai WP; Guan YJ; Gabrilovich DI; Zhou J
J Exp Med; 2018 Aug; 215(8):2157-2174. PubMed ID: 30049704
[TBL] [Abstract][Full Text] [Related]
14. Allergen immunotherapy combined with Notch pathway inhibitors improves HDM-induced allergic airway inflammation and inhibits ILC2 activation.
Tong Y; Wang L; Wang L; Song J; Fan J; Lai C; Bao J; Weng C; Wang Y; Shuai J; Zhang H; Zhang W
Front Immunol; 2023; 14():1264071. PubMed ID: 38371944
[TBL] [Abstract][Full Text] [Related]
15. Jia-Wei-Yu-Ping-Feng-San Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway Inflammation in Allergic Asthma.
Xue L; Li C; Ge G; Zhang S; Tian L; Wang Y; Zhang H; Ma Z; Lu Z
Front Pharmacol; 2021; 12():703724. PubMed ID: 34305612
[TBL] [Abstract][Full Text] [Related]
16. Mucosal-associated invariant T cells repress group 2 innate lymphoid cells in
Shimizu Y; Horigane-Konakai Y; Ishii Y; Sugimoto C; Wakao H
Front Immunol; 2022; 13():1005226. PubMed ID: 36458017
[TBL] [Abstract][Full Text] [Related]
17. Dopamine inhibits group 2 innate lymphoid cell-driven allergic lung inflammation by dampening mitochondrial activity.
Cao Y; Li Y; Wang X; Liu S; Zhang Y; Liu G; Ye S; Zheng Y; Zhao J; Zhu X; Chen Y; Xu H; Feng D; Chen D; Chen L; Liu W; Zhou W; Zhang Z; Zhou P; Deng K; Ye L; Yu Y; Yao Z; Liu Q; Xu H; Zhou J
Immunity; 2023 Feb; 56(2):320-335.e9. PubMed ID: 36693372
[TBL] [Abstract][Full Text] [Related]
18. Lung group 2 innate lymphoid cells differentially depend on local IL-7 for their distribution, activation, and maintenance in innate and adaptive immunity-mediated airway inflammation.
Takami D; Abe S; Shimba A; Asahi T; Cui G; Tani-Ichi S; Hara T; Miyata K; Ikutani M; Takatsu K; Oike Y; Ikuta K
Int Immunol; 2023 Nov; 35(11):513-530. PubMed ID: 37493250
[TBL] [Abstract][Full Text] [Related]
19. Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells.
Klein Wolterink RG; Serafini N; van Nimwegen M; Vosshenrich CA; de Bruijn MJ; Fonseca Pereira D; Veiga Fernandes H; Hendriks RW; Di Santo JP
Proc Natl Acad Sci U S A; 2013 Jun; 110(25):10240-5. PubMed ID: 23733962
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase Cθ controls type 2 innate lymphoid cell and T
Madouri F; Chenuet P; Beuraud C; Fauconnier L; Marchiol T; Rouxel N; Ledru A; Gallerand M; Lombardi V; Mascarell L; Marquant Q; Apetoh L; Erard F; Le Bert M; Trovero F; Quesniaux VFJ; Ryffel B; Togbe D
J Allergy Clin Immunol; 2017 May; 139(5):1650-1666. PubMed ID: 27746240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
